去乙酰化酶SIRT1的表达及活性调控机制

doi:10.3724/SP.J.1005.2010.01003

[an error occurred while processing this directive]

HEREDITAS ›› 2010, Vol. 32 ›› Issue (10): 1003-1008.doi: 10.3724/SP.J.1005.2010.01003

• en • Previous Articles Next Articles

Mechanism of regulating deacetylase SIRT1 expression and activity

YANG Wen-Jia, WANG Dong-Lai, ZHU Wei-Guo

School of Basic Medical Sciences, Peking University, Beijing 100191, China

Received:2010-01-31 Revised:2010-04-05 Online:2010-10-20 Published:2010-10-20
Contact: ZHU Wei-Guo E-mail:zhuweiguo@bjmu.edu.cn

Abstract

YANG Wen-Jia, WANG Dong-Lai, SHU Wei-Guo. Mechanism of regulating deacetylase SIRT1 expression and activity[J]. HEREDITAS, 2010, 32(10): 1003-1008.

[1] Sauve AA, Wolberger C, Schramm VL, Boeke JD. The biochemistry of sirtuins. Annu Rev Biochem, 2006, 75(1): 435–465. [2] Haigis MC, Guarente LP. Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction. Genes Dev, 2006, 20(21): 2913–2921. [3] Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J, 2007, 404(1): 1–13. [4] Nemoto S, Fergusson MM, Finkel T. Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science, 2004, 306(5704): 2105–2108. [5] Ford J, Jiang M, Milner J. Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival. Cancer Res, 2005, 65(22): 10457–10463. [6] Brooks CL, Gu W. How does SIRT1 affect metabolism, se-nescence and cancer? Nat Rev Cancer, 2009, 9(2): 123–128. [7] Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guar-ente L, Gu W. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell, 2001, 107(2): 137–148. [8] Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA. hSIR2(SIRT1) functions as an NAD+-dependent p53 deacetylase. Cell, 2001, 107(2): 149–159. [9] Motta MC, Divecha N, Lemieux M, Kamel C, Chen D, Gu W, Bultsma Y, McBurney M, Guarente L. SIRT1 represses fork-head transcription factors. Cell, 2004, 116(4): 551–563. [10] Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg ME. Stress-dependent regulation of FOXO tran-scription factors by the SIRT1 deacetylase. Science, 2004, 303(5666): 2011–2015. [11] Chen WY, Zeng X, Carter MG, Morrell CN, Chiu Yen RW, Esteller M, Watkins DN, Herman JG, Mankowski JL, Baylin SB. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat Genet, 2003, 33(2): 197–202. [12] Chen WY, Wang DH, Yen RC, Luo J, Gu W, Baylin SB. Tu-mor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell, 2005, 123(3): 437–448. [13] Zhang Q, Wang SY, Fleuriel C, Leprince D, Rocheleau JV, Piston DW, Goodman RH. Metabolic regulation of SIRT1 transcription via a HIC1: CtBP corepressor complex. Proc Natl Acad Sci USA, 2007, 104(3): 829–833. [14] Chen W, Cooper TK, Zahnow CA, Overholtzer M, Zhao Z, Ladanyi M, Karp JE, Gokgoz N, Wunder JS, Andrulis IL, LJvine AF, Mankowski JL, Baylin SB. Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumori-genesis. Cancer Cell, 2004, 6(4): 387–398. [15] Stankovic-Valentin N, Deltour S, Seeler J, Pinte S, Vergoten G, Guerardel C, Dejean A, Leprince D. An acetyla-tion/deacetylation-SUMOylation switch through a phyloge-netically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity. Mol Cell Biol, 2007, 27(7): 2661–2675. [16] Martinez-Balbas MA, Bauer UM, Nielsen SJ, Brehm A, Kouzarides T. Regulation of E2F1 activity by acetylation. EMBO J, 2000, 19(4): 662–671. [17] Wang C, Chen L, Hou X, Li Z, Kabra N, Ma Y, Nemoto S, Finkel T, Gu W, Cress WD, Chen J. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat Cell Biol, 2006, 8(9): 1025–1031. [18] Kwon HS, Ott M. The ups and downs of SIRT1. Trends Bio-chem Sci, 2008, 33(11): 517–525. [19] Abdelmohsen K, Pullmann R Jr, Lal A, Kim HH, Galban S, Yang X, Blethrow JD, Walker M, Shubert J, Gillespie DA, Furneaux H, Gorospe M. Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol Cell, 2007, 25(4): 543–557. [20] Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA, 2008, 105

Metrics

Comments

www.chinagene.cn
备案号：京ICP备09063187号

Mechanism of regulating deacetylase SIRT1 expression and activity

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Lingling Wu, Xiaoyu Zhang, Xiao Li, Jianjun Jin, Gongshe Yang, Xin’e Shi. miR-196b-5p promotes myoblast proliferation and differentiation [J]. Hereditas(Beijing), 2023, 45(5): 435-446.
[2]	Shunze Wang, Feng Jiang, Dongli Zhu, Tie-Lin Yang, Yan Guo. Application of Hi-C technology in three-dimensional genomics research and disease pathogenesis analysis [J]. Hereditas(Beijing), 2023, 45(4): 279-294.
[3]	Siyuan Xu, Jia Shou, Qiang Wu. Additional evidence of HS5-1 enhancer eRNA PEARL for protocadherin alpha gene regulation [J]. Hereditas(Beijing), 2022, 44(8): 695-764.
[4]	Yan Zhao, Chenxin Wang, Tianming Yang, Chunshuang Li, Lihong Zhang, Dongni Du, Ruoxi Wang, Jing Wang, Min Wei, Xueqing Ba. Linking oxidative DNA lesion 8-OxoG to tumor development and progression [J]. Hereditas(Beijing), 2022, 44(6): 466-477.
[5]	Sihan Qi, Qilin Wang, Junyou Zhang, Qian Liu, Chunyan Li. The regulatory mechanisms by enhancers during cancer initiation and progression [J]. Hereditas(Beijing), 2022, 44(4): 275-288.
[6]	Hui Qu, Yi Liu, Yawen Chen, Hui Wang. Alteration of imprinted genes and offspring organ development caused by environmental factors [J]. Hereditas(Beijing), 2022, 44(2): 107-116.
[7]	Qianbin Zhu, Zhicheng Gan, Xiaocui Li, Yingjie Zhang, Heming Zhao, Xianzhong Huang. Genome-wide identification, phylogenetic and expression of MAPKKK gene family in Arabidopsis pumila [J]. Hereditas(Beijing), 2022, 44(11): 1044-1055.
[8]	Cong Zhou, Qiangwei Zhou, Sheng Cheng, Guoliang Li. Research progress of CTCF in mediating 3D genome formation and regulating gene expression [J]. Hereditas(Beijing), 2021, 43(9): 816-821.
[9]	Ling Wang, Jinhuan Li, Haiyan Huang, Qiang Wu. Serial deletions of tandem reverse CTCF sites reveal balanced HOXD regulatory landscape of enhancers [J]. Hereditas(Beijing), 2021, 43(8): 775-791.
[10]	Hongyan Lin, Xuan Wang, Cong He, Ziling Zhou, Minkai Yang, Zhongling Wen, Hongwei Han, Guihua Lu, Jinliang Qi, Yonghua Yang. Progress on biosynthesis and function of the natural products of Zi Cao as a traditional Chinese medicinal herb [J]. Hereditas(Beijing), 2021, 43(5): 459-472.
[11]	Haidong Xu, Bolin Ning, Fang Mu, Hui Li, Ning Wang. Advances of functional consequences and regulation mechanisms of alternative cleavage and polyadenylation [J]. Hereditas(Beijing), 2021, 43(1): 4-15.
[12]	Taotao Wang, Yong Yang, Wei Wei, Chentao Lin, Liuyin Ma. Identification and expression analyses of the NAC transcription factor family in Spartina alterniflora [J]. Hereditas(Beijing), 2020, 42(2): 194-211.
[13]	Huiyou Chen, Jianmin Zhang, Baisen Li, Yonglin Deng, Gongwei Zhang. Progress on meiotic gene expression and epigenetic regulation of male sterility in Dzo cattle [J]. Hereditas(Beijing), 2020, 42(11): 1081-1092.
[14]	Xiaomeng Gao, Zhihua Zhang. Three-dimensional structure and function of chromatin regulated by “liquid-liquid phase separation” of biological macromolecules. [J]. Hereditas(Beijing), 2020, 42(1): 45-56.
[15]	Qichao Yu,Bin Song,Xuanxuan Zou,Ling Wang,Dequan Liu,Bo Li,Kun Ma. Analysis of normal tissues adjacent to the tumour-specific expressed genes in breast cancer [J]. Hereditas(Beijing), 2019, 41(7): 625-633.